Advances in Clinical Chemistry

Dr Gregory S Makowski is a board certified clinical chemist and fellow of the National Academy of Clinical Biochemistry. Following receipt of his PhD in Biochemistry from the University of Connecticut Storrs, he pursued post-doctoral studies at the University of Connecticut School of Medicine in Farmington that culminated in his joint appointments in the School of Medicine and the Department of Laboratory Medicine at John Dempsey Hospital. He has numerous clinical and basic science publications and serves on various scientific and editorial boards. He is actively engaged in the training of Pathology residents and fellows in the Department of Pathology and Laboratory Medicine at Hartford Hospital. He currently serves as Vice President and Chief Scientific Officer for Clinical Laboratory Partners in Newington CT, USA.

Biomarkers in Breast Cancer: Where Are We and Where Are We Going?
Michael J. Duffy, Siun Walsh, Enda W. McDermott and John Crown

Polycystic Ovary Syndrome- Epigenetic Mechanisms and Aberrant MicroRNA
Ioana R. Ilie and Carmen E. Georgescu

EN2 in Prostate Cancer
Sophie E. McGrath, Agnieszka Michael, Richard Morgan and Hardev Pandha.

Cytochrome P450 in Cancer Susceptibility and Treatment
Balraj Mittal, Sonam Tulsyan, Surendra Kumar, Rama Devi Mittal and Gaurav Agarwal

The Importance of Accurately Assessing Renal Function in the Neonate and Infant
Guido Filler, Laudelino Lopes and Mark Awuku

Systematic Assessment of the Hemolysis Index: Pros and Cons
Giuseppe Lippi

Peroxisome Proliferator-Activated Receptor a in Lipid Metabolism and AtherosclerosisXiao-Hua Yu, Xi-Long Zheng and Chao-Ke Tang